Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bayer, Novartis, Sanofi-Aventis Rated New ‘Buy’ at Deutsche Bank
Bayer, Novartis, Sanofi-Aventis Rated New ‘Buy’ at Deutsche Bank
Bayer, Novartis, Sanofi-Aventis Rated New ‘Buy’ at Deutsche Bank
Submitted by
admin
on November 16, 2009 - 9:10am
Source:
Bloomberg
News Tags:
upgrades
Bayer
Novartis
Sanofi
Headline:
Bayer, Novartis, Sanofi-Aventis Rated New ‘Buy’ at Deutsche Bank
Do Not Allow Advertisers to Use My Personal information
